Diagnosis and Treatment for Women's Health: Second Edition

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Women's Health Care".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 3760

Special Issue Editor

Special Issue Information

Dear Colleagues, 

This Special Issue entitled “Diagnosis and Treatment for Women's Health” will focus on the latest technological innovations and procedures that allow for the more accurate diagnosis and treatment of gynecological diseases. New diagnostic devices provide faster and more precise diagnoses. Technological innovations and the use of minimally invasive techniques, such as hysteroscopy, laparoscopy or robotic surgery, allow for early diagnosis and personalized treatment.

Dr. Stefano Restaino
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gynecology
  • gynecology surgery
  • female healthcare
  • endometrial cancer
  • ovarian cancer
  • mini-invasive surgery
  • laparoscopy
  • robotic surgery
  • hysteroscopy
  • ultrasound
  • cervical screening
  • preventive screening

Related Special Issue

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

22 pages, 4282 KiB  
Article
Usefulness of the Sympto-Thermal Method with Standardized Cervical Mucus Assessment (InVivo Method) for Evaluating the Monthly Cycle in Women with Polycystic Ovary Syndrome (PCOS)
by Aneta Stachowska, Aleksandra M. Kicińska, Anna Kotulak-Chrząszcz and Anna Babińska
Healthcare 2024, 12(11), 1108; https://doi.org/10.3390/healthcare12111108 - 29 May 2024
Viewed by 318
Abstract
(1) Background: FABMs (fertility awareness-based methods) are methods that rely on the observation of clinical signs related to fertility found in women, the so-called fertility bioindicators. They can be a valuable tool for diagnosing monthly cycle disorders and infertility, for example, among patients [...] Read more.
(1) Background: FABMs (fertility awareness-based methods) are methods that rely on the observation of clinical signs related to fertility found in women, the so-called fertility bioindicators. They can be a valuable tool for diagnosing monthly cycle disorders and infertility, for example, among patients with PCOS (polycystic ovary syndrome). Until now, it has been difficult for women with PCOS to use FABM, due to the difficulty of describing fertility bioindicators and their disorders due to the biology of the syndrome. The new InVivo sympto-thermal method with standardized cervical mucus assessment may provide a valuable diagnostic and therapeutic tool for observing the monthly cycle in this group of women. (2) Methods: The monthly cycle was evaluated in a group of 32 women of reproductive age. A total of 108 monthly cycle observation cards were analyzed: 35 monthly cycle cards were collected from 18 women with PCOS, and 73 monthly cycle cards collected from 14 healthy women. In addition, 32 pairs of macroscopic and microscopic images were evaluated: 17 pairs from the study group (four subjects) and 15 pairs from women in the control group (six subjects). (3) Results: We showed that in the group of patients with PCOS, menstruation was longer (p = 0.000814), the number of mucus peaks was statistically higher (p = 0.040747), and the interquartile range (IQR) of the duration of the follicular phase (calculated according to the BBT) was significantly higher (8 days) compared to women in the control group. We also observed that among all the women studied, the microscopic image of cervical mucus correlated with the cycle phase described in the observation card, as determined by reference to the BBT chart, provided that it showed the correct features. (4) Conclusions: Systematic maintenance of monthly cycle observation charts using the InVivo method can be an important supplement to the medical history, as it allows for a thorough assessment of, among others, the timing of monthly bleeding, cervical mucus symptoms, BBT changes, and the duration of the follicular and luteal phases among both healthy and PCOS women. Full article
(This article belongs to the Special Issue Diagnosis and Treatment for Women's Health: Second Edition)
Show Figures

Figure 1

Other

Jump to: Research

10 pages, 526 KiB  
Protocol
Transcutaneous Tibial Nerve Stimulation for Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial
by Marta Correyero-León, Rocío Llamas-Ramos, Javier Calvo-Rodrigo, Jorge Juan Alvarado-Omenat and Inés Llamas-Ramos
Healthcare 2023, 11(11), 1633; https://doi.org/10.3390/healthcare11111633 - 2 Jun 2023
Cited by 1 | Viewed by 1399
Abstract
Primary dysmenorrhea (PD) is a painful menstruation that can persist for the duration of a woman’s fertile life. Non-steroidal anti-inflammatory drugs, hormonal therapy, physiotherapy techniques, etc., are the main treatments. The main objective of this study is to evaluate the effectiveness of transcutaneous [...] Read more.
Primary dysmenorrhea (PD) is a painful menstruation that can persist for the duration of a woman’s fertile life. Non-steroidal anti-inflammatory drugs, hormonal therapy, physiotherapy techniques, etc., are the main treatments. The main objective of this study is to evaluate the effectiveness of transcutaneous posterior tibial nerve stimulation (TTNS) in PD patients. The study will consist of a single-blind randomized clinical trial, parallel-assigned with two arms. Women with PD (18–43 years) with regular menstrual cycles and at least 4 points in VAS will be randomly divided into experimental (TTNS) and placebo (simulated stimulation) groups during 12 treatment sessions (1 session/week) and several follow-ups: monthly during treatment and 1, 3 and 6 months after. Maximum and mean pain intensity, pain duration, pain severity, number of anti-inflammatory drugs, quality of life, sleep quality, overall improvement, treatment satisfaction and secondary effects will be measured once a month every 6 months and at 3 and 6 months. The Student’s t-test for independent samples or the Mann–Whitney U test will be used. The literature shows effective physiotherapeutic techniques for PD in the short term, which do not act on causes and have limitations. The TTNS technique can be used in transcutaneous and percutaneous modalities, with similar effectiveness, but the transcutaneous causes less discomfort. TTNS modulates pain, and long-term benefits could be achieved at low cost and without patient discomfort. Full article
(This article belongs to the Special Issue Diagnosis and Treatment for Women's Health: Second Edition)
Show Figures

Figure 1

9 pages, 3880 KiB  
Case Report
Large Pelvic Mass in a Female Adolescent: Atypical Presentation and Successful Treatment of Extraskeletal Ewing Sarcoma
by Federica Perelli, Giuseppe Vizzielli, Anna Franca Cavaliere, Stefano Restaino, Giovanni Scambia, Gian Franco Zannoni, Damiano Arciuolo and Valerio Gallotta
Healthcare 2023, 11(10), 1373; https://doi.org/10.3390/healthcare11101373 - 10 May 2023
Cited by 1 | Viewed by 1579
Abstract
Extraskeletal Ewing sarcoma is a rare soft tissue tumor primarily affecting pediatric patients. The treatment is currently based on a multidisciplinary approach which allows, in cases of localized disease, good survival rates. We report the case of a 15-year-old female patient with a [...] Read more.
Extraskeletal Ewing sarcoma is a rare soft tissue tumor primarily affecting pediatric patients. The treatment is currently based on a multidisciplinary approach which allows, in cases of localized disease, good survival rates. We report the case of a 15-year-old female patient with a rapidly growing suspected pelvic mass misdiagnosed following the preliminary radiological exams, which assessed the findings as a mass of ovarian origin. The girl underwent surgery and, thanks to histopathological, immunohistochemical and real-time polymerase chain reaction (RT-PCR) examinations, it was possible to make the right diagnosis and to administer the best treatment in terms of surgery, chemotherapy and radiotherapy, obtaining a long disease-free interval and no recurrence to date. Full article
(This article belongs to the Special Issue Diagnosis and Treatment for Women's Health: Second Edition)
Show Figures

Figure 1

Back to TopTop